Cite
HARVARD Citation
Hashimoto, K. et al. (2020). Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer. Cancer medicine. pp. 8579-8588. [Online].